Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT06586047 | Breast Cancer PSMA PET | EARLY_PHASE1 | RECRUITING | 30 | — | — | Aug 29, 2024 | Dec 29, 2026 | Mar 27, 2026 | 1 | United States |
Comparing the sensitivity of 18 F-DCFPyL-PET/CT and FDG PET/CT in metastatic lesion detection in triple-negative breast cancer patients.
| Arm | Type | Description |
|---|---|---|
| PET Imaging of breast cancer patients | EXPERIMENTAL | Triple negative breast cancer patients will undergo FDG PET/CT and Pyl PET/Ct |
| Name | Type | Description |
|---|---|---|
| PET imaging | DIAGNOSTIC_TEST | Imaging with FDG PET/CT and Pyl PET/CT in triple negative breast cancer |
Inclusion Criteria: * Female \>= 18 years of age * Patients in distantly metastatic TNBC based on the initial diagnosis biopsy. * Patient should have FDG positive metastatic lesions on the initial PET/CT scan performed in this study to be further included. Exclusion Criteria: * Patients with know...